Lineage Cell Therapeutics (LCTX) Long-Term Investments (2015 - 2017)
Lineage Cell Therapeutics (LCTX) posted Long-Term Investments of $36.54 million for Q2 2019, down 45.3% from $66.78 million a year earlier and down 37.0% from the prior quarter.
Powered by 
Analysis
Lineage Cell Therapeutics (LCTX) Long-Term Investments (2015 - 2017) Analysis & Trends
At the end of FY2018, Lineage Cell Therapeutics' Long-Term Investments came in at $33.73 million, down 71.2% from FY2017.
- Annual Long-Term Investments shows a three-year compound annual growth rate of 93.3% (FY2015 to FY2018).
- In prior years, Lineage Cell Therapeutics' Long-Term Investments was $117.17 million in FY2017 and $4.67 million in FY2015.
- Quarterly Long-Term Investments has run from a low of $3.48 million in Q3 2016 to a high of $184.73 million in Q3 2017 over five years.
- On a year-over-year basis, Long-Term Investments has declined in each of the last six quarters, with an average decline of 41.7% over the last six quarters.
- According to Business Quant data, Long-Term Investments for the three prior quarters was $57.96 million (Q1 2019), $33.73 million (Q4 2018) and $108.21 million (Q3 2018).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,230.11 Bn | 1,198.70 Bn | 19.71 Bn | 3.86 Bn |
| 2 | Johnson & Johnson | 644.39 Bn | 564.25 Bn | 17.30 Bn | - |
| 3 | AbbVie | 503.52 Bn | 476.68 Bn | 12.70 Bn | 266.00 Mn |
| 4 | Merck | 363.29 Bn | 317.72 Bn | 12.21 Bn | 1.22 Bn |
| 5 | Novartis Ag | 298.23 Bn | 262.62 Bn | 11.24 Bn | 69.00 Mn |
| 6 | Astrazeneca | 267.53 Bn | 241.29 Bn | 12.86 Bn | 297.00 Mn |
| 7 | Amgen | 241.80 Bn | 197.20 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 195.07 Bn | 169.19 Bn | 6.22 Bn | - |
| 9 | Pfizer | 173.33 Bn | 120.28 Bn | 10.94 Bn | 1.56 Bn |
| 10 | Lineage Cell Therapeutics | 247.85 Mn | 46.25 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2017 | 87.31 Mn |
| Sep 30, 2016 | 3.48 Mn |
| Jun 30, 2016 | 4.34 Mn |
| Mar 31, 2016 | 4.44 Mn |
| Dec 31, 2015 | 4.67 Mn |
API Access
Lineage Cell Therapeutics Long-Term Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=long-term-investments&ticker=LCTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "long-term-investments", "ticker": "LCTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=long-term-investments&ticker=LCTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();